Nobel Peace Prize Laureate 2015; President of The Tunisian Confederation of Industry, Trade and Handicrafts (UTICA)
2018 Noble Prize in Chemistry awardee. Speaker Gregory Winter is a pioneer in the fields of genetic and protein engineering. Organizations book Gregory Winter to learn about his techniques that have enabled cancer’s antibody therapies and therapies for other diseases like multiple sclerosis and rheumatoid arthritis.
Want to book Gregory Winter as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Science speaker Gregory Winter was one of three co-winners of the 2018 Nobel Prize in Chemistry, alongside Frances Arnold and George P. Smith. He attended the University of Cambridge, where he took Natural Sciences. He subsequently went on to earn his Ph.D. at Cambridge Laboratory of Molecular Biology. Furthermore, he worked at LMB on the amino acid sequence of Bacillus stearothermophilus tryptophanyl tRNA synthetase.
Gregory Winter conducted most of his studies at the MRC Centre for Protein Engineering and at the Laboratory of Molecular Biology. In 1981, Gregory became a Programme Leader. Later on, he joined the PNAC Division as Joint Head. Subsequently, Gregory Winter became the LMB’s Deputy Director and then acting Director. Additionally, from 1990 until the organization’s closure in 2010, he served as Deputy Director of CPE.
His primary scientific interests are in the fields of genetic and protein engineering. When he first started researching antibodies, speaker Gregory Winter developed an interest in the fact that antibodies possess a basic identic structure. Antibodies have just minor differences distinguishing them as specific for one target. As a leader in the field of humanized and human therapeutic antibodies, he was successful in developing antibody therapies for cancer, as well as multiple sclerosis and rheumatoid arthritis. Gregory is the founder of Cambridge Antibody Technology, Bicycle Therapeutics, and Domantis.
He has served as Master of Trinity College in Cambridge from 2012 to 2019. Gregory Winter has had several remarkable achievements throughout his career. In 1987, he joined the European Molecular Biology Organisation. Later, in 1990, he became a Royal Society fellow. Finally, in 2006, he became a Fellow of the Academy of Medical Sciences. The 2018 Nobel Prize in Chemistry was his most recent award. In 2004, he was knighted for his work in molecular biology
In 2020, Gregory Winter was featured on The Times’ ‘Science Power List’.
Sir Greg Winter pioneered techniques that have led to antibody therapies for cancer, and diseases such as rheumatoid arthritis and multiple sclerosis. He has established hugely successful spin out companies, including Cambridge Antibody Technology and Domantis, and continues to develop new types of drugs. His technologies are involved in around 65 per cent of marketed antibody drugs today, including Humira and Herceptin.
|Basic Data Protection Information|
|Data controller||AURUM SPEAKERS BUREAU S.L.|
|Address||Doctor Ullés 2, 3º 1ª, CP 08224, TERRASSA (Barcelona)|
|Purposes||We will use your data to respond to your requests and deliver our services to you.|
|Marketing||We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose.|
|Lawful basis||We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose.|
|Recipients||Generally, only our members of staff who have been duly authorised may access the data that you have provided.|
|Your Rights||You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website.|